|
Market Closed -
Australian S.E.
09:11:03 12/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 3.760 AUD | +3.30% |
|
+11.24% | +66.37% |
| 10-12 | Cogstate Contracted Fiscal 2027 Revenue Rises to $56.8 Million After September Quarter Sales | MT |
| 09-25 | Morgans Financial Starts Cogstate at Buy with AU$4.07 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COGSTATE LIMITED | Other Biotechnology & Medical Research | +3.30% | +11.24% | +66.37% | +31.01% | +57.32% | 429M |  |  | |
- Stock Market
- Stocks
- CGS Stock
- Charts Cogstate Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
